Interdisciplinary BioInnovation PhD from Tulane University (translational research + MBA coursework), a program training scientist entrepreneurs. Developed high-throughput synthetic biology tools for phage engineering. Multidrug-resistant organisms represent one of the greatest emerging health threats. Phage therapy is a resurgent practice using bacterial viruses for precision treatment of infections. Four years prior experience in a biotech startup. Post PhD, the first postdoctoral Innovation Fellow at Tulane, aimed at launching BioPhoundry as a commercial venture. Raised pre-seed funding and officially launched in 2025. Led our R&D to generate custom phage products with commercially viable turnaround time and scale, and to complete our first industry contracts and clinical pilot studies.